Pten regulates epithelial cytodifferentiation during prostate development

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Lokody, Isabel B ^a   Francis, Jeffrey C ^a   Gardiner, Jennifer R ^a   Erler, Janine T ^a,b   Swain, Amanda ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CLU PROTEIN, MOUSE; CLUSTERIN; PTEN PROTEIN, MOUSE; TROP2 PROTEIN, MOUSE; TUMOR ANTIGEN;

ADULT; ANDROGEN RECEPTOR GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOSS; MALE; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PROSTATE DEVELOPMENT; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PTEN GENE; RECEPTOR GENE; REGULATOR GENE; ANIMAL; CLUSTER ANALYSIS; CYTOLOGY; EMBRYOLOGY; EPITHELIUM CELL; GENETICS; METABOLISM; PHYSIOLOGY; PROSTATE; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; ANTIGENS, NEOPLASM; BIOMARKERS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CLUSTER ANALYSIS; CLUSTERIN; EPITHELIAL CELLS; GENE DELETION; MALE; MICE; PROSTATE; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84936966660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129470     Document Type: Article

References (42)

1. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, et al. The endocrinology and developmental biology of the prostate. Endocr Rev. 1987; 8: 338-362. PMID: 3308446
2. Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008; 27: 7180-7191. doi: 10.1038/onc.2008.327 PMID: 18794802
3. Pritchard C, Mecham B, Dumpit R, Coleman I, Bhattacharjee M, Chen Q, et al. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. Cancer Res. 2009; 69: 1739-1747. doi: 10.1158/0008-5472.CAN-07-6817 PMID: 19223557
4. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998; 19: 348-355. PMID: 9697695
5. Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N, et al. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development. 2002; 129: 4159-4170. PMID: 12163417
6. Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003; 63: 674-681. PMID: 12566313
7. Yanagi S, Kishimoto H, Kawahara K, Sasaki T, Sasaki M, Nishio M, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest. 2007; 117: 2929-2940. PMID: 17909629
8. Dahia PL PTEN, a unique tumor suppressor gene. Endocr Relat Cancer. 2000; 7: 115-129. PMID: 10903528
9. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 1998; 58: 204-209. PMID: 9443392
10. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18: 11-22. doi: 10.1016/j.ccr.2010.05.026 PMID: 20579941
11. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999; 96: 1563-1568. PMID: 9990064
12. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003; 4: 209-221. PMID: 14522255
13. Thomsen MK, Butler CM, Shen MM, Swain A Sox9 is required for prostate development. Dev Biol. 2008; 316: 302-311. doi: 10.1016/j.ydbio.2008.01.030 PMID: 18325490
14. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, et al. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis. 2002; 32: 148-149. PMID: 11857804
15. Francis JC, Thomsen MK, Taketo MM, Swain A beta-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma. PLoS Genet. 2013; 9: e1003180. doi: 10.1371/journal.pgen.1003180 PMID: 23300485
16. Gardiner JR, Jackson AL, Gordon J, Lickert H, Manley NR, Basson MA Localised inhibition of FGF signalling in the third pharyngeal pouch is required for normal thymus and parathyroid organogenesis. Development. 2012; 139: 3456-3466. doi: 10.1242/dev.079400 PMID: 22912418
17. Soriano P Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999; 21: 70-71. PMID: 9916792
18. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95: 29-39. PMID: 9778245
19. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One. 2009; 4: e5662. doi: 10.1371/journal.pone.0005662 PMID: 19461893
20. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P, et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res. 2005; 65: 5730-5739. PMID: 15994948
21. Sugimura Y, Cunha GR, Donjacour AA, Bigsby RM, Brody JR Whole-mount autoradiography study of DNA synthetic activity during postnatal development and androgen-induced regeneration in the mouse prostate. Biol Reprod. 1986; 34: 985-995. PMID: 3730490
22. Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, et al. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell. 2011; 19: 792-804. doi: 10.1016/j.ccr.2011.05.006 PMID: 21620777
23. Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell. 2011; 19: 575-586. doi: 10.1016/j.ccr.2011.04.008 PMID: 21575859
24. Wang Y, Hayward S, Cao M, Thayer K, Cunha G Cell differentiation lineage in the prostate. Differentiation. 2001; 68: 270-279. PMID: 11776479
25. Thomson AA, Marker PC Branching morphogenesis in the prostate gland and seminal vesicles. Differentiation. 2006; 74: 382-392. PMID: 16916376
26. Donjacour AA, Cunha GR Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology. 1993; 132: 2342-2350. PMID: 7684975
27. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008; 105: 20882-20887. doi: 10.1073/pnas.0811411106 PMID: 19088204
28. Leong KG, Wang BE, Johnson L, Gao WQ Generation of a prostate from a single adult stem cell. Nature. 2008.
29. Koltai T Clusterin: a key player in cancer chemoresistance and its inhibition. Onco Targets Ther. 2014; 7: 447-456. doi: 10.2147/OTT.S58622 PMID: 24672247
30. Higano CS Potential use of custirsen to treat prostate cancer. Onco Targets Ther. 2013; 6: 785-797. doi: 10.2147/OTT.S33077 PMID: 23836992
31. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via beta-catenin signaling. Genes Dev. 2012; 26: 2271-2285. doi: 10.1101/gad.196451.112 PMID: 23070813
32. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene. 2013; 32: 222-233. doi: 10.1038/onc.2012.36 PMID: 22349828
33. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999; 13: 966-977. PMID: 10215624
34. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A. 2002; 99: 2884-2889. PMID: 11854455
35. Van de Sande T, Roskams T, Lerut E, Joniau S, Van Poppel H, Verhoeven G, et al. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB. J Pathol. 2005; 206: 214-219. PMID: 15880754
36. Ghosh S, Lau H, Simons BW, Powell JD, Meyers DJ, De Marzo AM, et al. PI3K/mTOR signaling regulates prostatic branching morphogenesis. Dev Biol. 2011; 360: 329-342. doi: 10.1016/j.ydbio.2011.09.027 PMID: 22015718
37. Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014; 19: 393-406. doi: 10.1016/j.cmet.2014.01.019 PMID: 24606897
38. Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, et al. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell. 2006; 9: 367-378. PMID: 16697957
39. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci U S A. 2006; 103: 1480-1485. PMID: 16432235
40. Choi N, Zhang B, Zhang L, Ittmann M, Xin L Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell. 2012; 21: 253-265. doi: 10.1016/j.ccr.2012.01.005 PMID: 22340597
41. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol. 2013; 15: 274-283. doi: 10.1038/ncb2697 PMID: 23434823
42. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009; 461: 495-500. doi: 10.1038/nature08361 PMID: 19741607